ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Test performance of PET-CT for mediastinal lymph node staging of pulmonary carcinoid tumours

Friday, August 15, 2014

Submitted by

Mark Ferguson

Source

Source Name: Thorax

Source URL: http://thorax.bmj.com/content/early/2014/08/14/thoraxjnl-2014-205899?papetoc

Author(s)

Holly A Pattenden, Maria Leung, Emma Beddow, Michael Dusmet, Andrew G Nicholson, Michael Shackcloth, Saifullah Mohamed, Adnan Darr, Babu Naidu, Swetha Iyer, Adrian Marchbank, Amy Greenwood, Doug West, Felice Granato, Alan Kirk, Priyadharshanan Ariyaratnam, Mahmoud Loubani, Eric Lim

This retrospective study involving 7 institutions evaluated the utility of PET for mediastinal staging in patients who had undergone resection of pulmlonary carcinoid tumors and nodal dissection. 88% of pts had typical carcinoid tumors. The sensitivity of PET was only 33%, whereas the specificity was 94%.